Bone is a highly vascularized tissue that relies on a close spatial and temporal interaction
between blood vessels and bone cells. As a result, angiogenesis is critical for bone …

Isoflavones and bone health in perimenopausal and postmenopa... : Current Opinion in
Clinical Nutrition & Metabolic Care Isoflavones and bone health in perimenopausal and …

Bone loss or osteoporosis, is a slow-progressing disease that results from dysregulation of
pro-inflammatory cytokines. The FDA has approved number of drugs for bone loss …

Flavonoids, a group of natural compounds found in a variety of vegetables and herbal
medicines, have been intensively reported on regarding their estrogen-like activities and …

Efficient therapies are available for the treatment of osteoporosis. Anti‐resorptive therapies,
including bisphosphonates and denosumab, increase bone mineral density (BMD) and …

Phytoestrogens have the potential to maintain bone health and delay or prevent
osteoporosis. This review focuses on their dose-dependent effects on bone and their …

Introduction: Osteoporosis is a highly prevalent skeletal disorder characterized by
compromised bone strength, usually related to decreased bone mass and microstructural …

Osteoporosis refers to excessive bone loss as reflected by the deterioration of bone mass
and microarchitecture, which compromises bone strength. It is a complex multifactorial …

Isoflavones have a structure similar to 17β-estradiol, so they may be useful to
postmenopausal women in preventing bone loss related to estrogen deficiency. The present …

Osteoporosis (OP) is a metabolic disease that affects bone, resulting in a progressive
decrease in bone mass, quality, and micro-architectural degeneration. Natural products …